Showing results (21-30 of 80) with videos related to
Sort By:
Pageof 8
AAPS Pharmscitech|November 8, 2017
Chemometric Methods to Quantify 1D and 2D NMR Spectral Differences Among Similar Protein TherapeuticsKang Chen, Junyong Park, Feng Li, et al.Journal of Medicinal Chemistry|June 11, 2008
The micelle-associated 3D structures of Boc-Y(SO3)-Nle-G-W-Nle-D-2-phenylethylester (JMV-180) and CCK-8(s) share conformational elements of a calculated CCK1 receptor-bound modelMohanraja Kumar, Joseph R Reeve, Weidong Hu, et al.Pancreas|March 27, 2003
Receptor subtypes: species variations in secretin affect potency for pancreatic but not gastric secretionTravis E Solomon, David A Keire, Peixian Gong, et al.Journal of Pharmaceutical and Biomedical Analysis|March 28, 2017
Heparin and homogeneous model heparin oligosaccharides form distinct complexes with protamine: Light scattering and zeta potential analysisCynthia D Sommers, Hongping Ye, Jian Liu, et al.Analytical Chemistry|May 7, 2020
Multiplexed Comparative Analysis of Intact Glycopeptides Using Electron-Transfer Dissociation and Synchronous Precursor Selection Based Triple-Stage Mass SpectrometryHongbin Zhu, Chen Qiu, Connie M Gryniewicz-Ruzicka, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|April 11, 2003
CCK-58 is the only detectable endocrine form of cholecystokinin in ratJoseph R Reeve, Gary M Green, Peter Chew, et al.The Analyst|April 13, 2013
Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometryBo Wang, Ashley C Gucinski, David A Keire, et al.The AAPS Journal|March 11, 2026
Minimizing in Source Fragmentation for Mass Spectrometry Based NDSRI Analytical Procedures: A Case Study of Nitroso-bumetanideJinhui Zhang, Mack Shih, Jingyue Yang, et al.Analytical Chemistry|November 13, 2010
Characterization of currently marketed heparin products: reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digestsAdam M Brustkern, Lucinda F Buhse, Moheb Nasr, et al.Journal of Pharmaceutical and Biomedical Analysis|March 18, 2010
Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approachesDavid A Keire, Daniel J Mans, Hongping Ye, et al.Pageof 8